MeSH tree: E02.095.465.425.400
A study of over 50,000 pregnant women in Norway during the 2023/24 influenza season found that only 29.9% were vaccinated against influenza and 12.1% against COVID-19 during pregnancy, remaining far below recommended targets. ...
Feb 19, 2026
0
7
In 2024, Professor Sebastian Kobold's research group at LMU University Hospital had already shown that the metabolite prostaglandin E2 can block T cells—the killer cells of the immune system—in the vicinity of a tumor, such ...
Feb 16, 2026
0
17
More Americans than expected enrolled in Affordable Care Act health insurance plans for this year, after premium subsidies were dramatically cut—but it remains to be seen whether they'll keep the coverage as their costs mount.
Feb 12, 2026
0
5
10,000 families participating in research by The Kids Research Institute Australia have demonstrated the effectiveness of a simple text message for increasing the number of children receiving their vaccinations on time. Throughout ...
Feb 12, 2026
0
4
As measles outbreaks spread across the United States, a top Trump administration health official is urging families to protect themselves by getting vaccinated.
Feb 10, 2026
0
3
Mexico's most populous state said Monday it was stepping up health screening at schools and recommended the use of face masks for students and staff as the country confronts a growing measles outbreak.
Feb 10, 2026
0
6
Dana-Farber Cancer Institute-led research helped drive an FDA label update for axicabtagene ciloleucel (Yescarta) that removes a prior exclusion for patients with primary central nervous system lymphoma, a rare and aggressive ...
Feb 9, 2026
0
8
Health officials in San Bernardino County, California, have confirmed the first case of measles in the county since 2023. The county's Department of Public Health said the case involves an unvaccinated child who was visiting ...
Feb 9, 2026
0
6
Chimeric antigen receptor (CAR) T cell therapy, a type of immunotherapy that leverages the immune system to combat diseases, is a powerful treatment option for certain cancers. The treatment relies on genetically modified ...
Feb 9, 2026
0
12
In a first-in-human study, researchers at The University of Texas MD Anderson Cancer Center observed strong responses and early signs of antitumor activity in patients with difficult-to-treat non-Hodgkin lymphomas who received ...
Feb 9, 2026
0
6
